Reports - Peptide Therapeutics Market
HealthcarePeptide Therapeutics Market
Peptide Therapeutics Market Valuation and Future Projections to 2035 by Type (Branded Peptides, Generic Peptides) by Application (Metabolic Disorders, Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Central Nervous System Disorders, Respiratory Disorders, Pain Management, Rental Disorders, Dermatology, Other Applications) by Route of Administration (Parenteral, Oral, Other Routes of Administration) by Manufacturer Type (In-house, Outsourced) by Synthesis Technology (Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), Hybrid Technology) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Global Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. Global Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. Global Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. Global Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. Global Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. Global Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. Global Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
9. Global Peptide Therapeutics Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Peptide Therapeutics Market - Segment Analysis
1. Overview
2. North America Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. North America Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. North America Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. North America Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. North America Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. North America Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. North America Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
Chapter 5 Europe Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Europe Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. Europe Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. Europe Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. Europe Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. Europe Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. Europe Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. Europe Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
Chapter 6 Asia Pacific Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. Asia Pacific Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. Asia Pacific Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. Asia Pacific Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. Asia Pacific Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. Asia Pacific Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
Chapter 7 Latin America Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Latin America Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. Latin America Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. Latin America Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. Latin America Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. Latin America Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. Latin America Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. Latin America Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
Chapter 8 Middle East & Africa Peptide Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa Peptide Therapeutics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Peptide Therapeutics Market - by Type
3.1. By Branded Peptides
3.2. By Generic Peptides
4. Middle East & Africa Peptide Therapeutics Market - by Application
4.1. By Metabolic Disorders
4.2. By Cancer
4.3. By Cardiovascular Disorders
4.4. By Gastrointestinal Disorders
4.5. By Central Nervous System Disorders
4.6. By Respiratory Disorders
4.7. By Pain Management
4.8. By Rental Disorders
4.9. By Dermatology
4.10. By Other Applications
5. Middle East & Africa Peptide Therapeutics Market - by Route of Administration
5.1. By Parenteral
5.2. By Oral
5.3. By Other Routes of Administration
6. Middle East & Africa Peptide Therapeutics Market - by Manufacturer Type
6.1. By In-house
6.2. By Outsourced
7. Middle East & Africa Peptide Therapeutics Market - by Synthesis Technology
7.1. By Liquid Phase Peptide Synthesis (LPPS)
7.2. By Solid Phase Peptide Synthesis (SPPS)
7.3. By Hybrid Technology
8. Middle East & Africa Peptide Therapeutics Market - by Distribution Channel
8.1. By Hospital Pharmacies
8.2. By Retail Pharmacies
8.3. By Online Pharmacies
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Eli Lilly and Company (U.S.)
2. Pfizer Inc. (U.S.)
3. Amgen Inc. (U.S.)
4. Takeda Pharmaceutical Company Limited (Japan)
5. AstraZeneca PLC (UK)
6. Teva Pharmaceutical Industries Ltd. (Israel)
7. Sanofi (France)
8. F. Hoffmann-La Roche Ltd. (Switzerland)
9. Novartis AG (Switzerland)
10. Novo Nordisk A/S (Denmark)
11. GlaxoSmithKline PLC (UK)
12. Ironwood Pharmaceuticals Inc. (U.S.)
13. Radius Health Inc. (U.S.)
14. Ipsen Pharma (France)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By